4//SEC Filing
MERRIMACK PHARMACEUTICALS INC 4
Accession 0001179110-13-017228
CIK 0001274792operating
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 11:36 AM ET
Size
6.9 KB
Accession
0001179110-13-017228
Insider Transaction Report
Form 4
McClements William M.
SVP of Corporate Operations
Transactions
- Purchase
Common Stock
2013-11-27$3.56/sh+6,000$21,340→ 6,000 total - Purchase
Common Stock
2013-11-29$3.91/sh+1,000$3,915→ 7,000 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.5101 to $3.6499, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.91 to $3.9195, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.
Documents
Issuer
MERRIMACK PHARMACEUTICALS INC
CIK 0001274792
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001274792
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 11:36 AM ET
- Size
- 6.9 KB